Nexgen Arrays

Nexgen Arrays Overview

Founded 2013
Status Private
Employees 5
Latest Deal Type Grant
Latest Deal Amount $374K
Latest Deal Amount
Investors 3

Nexgen Arrays General Information


Developer of a diagnostic technology for detecting Ebola viruses. The company provides a molecular diagnostic platform that enables medical specialists to detect viral diseases such as Ebola, Lassa and Marburg.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Social/Platform Software
Primary Office
  • 8 Saint Mary's Street
  • Boston, MA 02215
  • United States
+1 (617) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Nexgen Arrays Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Grant 01-Jan-2015 $374K Completed Startup
2. Grant 30-Sep-2014 0000 Completed Startup
1. Accelerator/Incubator 01-Jan-2014 Completed Startup

Nexgen Arrays Executive Team (2)

Name Title Board Seat Contact Info
George Daaboul Ph.D Co-Founder & Chief Scientific Officer
David Freedman Ph.D Co-Founder & Chief Executive Officer

Nexgen Arrays Investors (3)

To view Nexgen Arrays‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Institutes of Health Government 000 0000 000000 0
National Science Foundation Government 000 0000 000000 0
MassChallenge Accelerator/Incubator 000 0000 000000 0

Ready to get started?

Request a free trial